Ace the Anesthesia Challenge 2026 – Master the AKT-24 with Confidence!

Dilaudid, also known as hydromorphone, is primarily metabolized in the liver through phase 2 glucuronidation. In this metabolic pathway, hydromorphone undergoes conjugation, which involves the addition of a glucuronic acid molecule to the drug. This process decreases the drug's activity and increases its water solubility, facilitating its elimination from the body through urine.

Glucuronidation is significant for many opioids, as it helps in detoxifying and preparing them for excretion. The metabolites produced through this phase are usually less active, which also contributes to the controlled pharmacological effects of the drug. Understanding this metabolic route is crucial for anticipating drug interactions and side effects, particularly in patients with liver impairment who may have altered drug metabolism.

In contrast, other metabolic pathways mentioned in the options, such as phase 1 oxidation or elimination without metabolism, do not apply to Dilaudid, as these would not accurately represent its primary route of metabolism.